Effects of miR-193a and sorafenib on hepatocellular carcinoma cells

BACKGROUND: Hepatocellular carcinoma (HCC) is a challenging malignancy of global importance, it is the third most common cause of cancer-related mortality worldwide. In the last years the multikinase inhibitor sorafenib has been used for advanced HCC, but some patients do not benefit from this thera...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Salvi, Alessandro, Conde, Isabel, Abeni, Edoardo, Arici, Bruna, Grossi, Ilaria, Specchia, Claudia, Portolani, Nazario, Barlati, Sergio, De Petro, Giuseppina
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029516/
https://ncbi.nlm.nih.gov/pubmed/24330766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-12-162
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia